Form 8-K - Current report:
SEC Accession No. 0001213900-24-092879
Filing Date
2024-10-31
Accepted
2024-10-31 16:05:39
Documents
16
Period of Report
2024-10-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0219340-8k_neuro.htm   iXBRL 8-K 26879
2 AMENDED AND RESTATED EXCLUSIVE DEVELOPMENT AND DISTRIBUTION AGREEMENT, DATED OCT ea021934001ex10-1_neuro.htm EX-10.1 341157
3 PRESS RELEASE DATED OCTOBER 31, 2024 ea021934001ex99-1_neuro.htm EX-99.1 12806
4 GRAPHIC ex99-1_001.jpg GRAPHIC 13142
  Complete submission text file 0001213900-24-092879.txt   643610

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE nmtc-20241025.xsd EX-101.SCH 3006
6 XBRL LABEL FILE nmtc-20241025_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE nmtc-20241025_pre.xml EX-101.PRE 22353
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0219340-8k_neuro_htm.xml XML 3582
Mailing Address 7599 ANAGRAM DR EDEN PRAIRIE MN 55344
Business Address 7599 ANAGRAM DR EDEN PRAIRIE MN 55344 (952) 426-1383
NEUROONE MEDICAL TECHNOLOGIES Corp (Filer) CIK: 0001500198 (see all company filings)

EIN.: 270863354 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-40439 | Film No.: 241415226
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)